1. DeVita VT Jr, Hellman S, Rosenberg SA, editors. Biologic therapy of cancer. 2nd ed. Philadelphia, PA: J.B. Lippincott; 1995. p. 295–327.
2. Oldham RK. Biologicals and biological response modifiers: the fourth modality of cancer treatment. Cancer Treat Rep. 1984;68:221–32.
3. Eberhard A, Kahlert S, Goede V, et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 2000;60:1388–93.
4. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669–76.
5. Yeo TK, Dvorak HF. Tumor stroma. In: Colvin R, Bhan A, McCluskey R, editors. Diagnostic immunopathology. New York: Raven Press; 1995. p. 485–697.